Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada
Lau J, Scott MM, Everett K, Gomes T, Tanuseputro P, Jennings S, Bagnarol R, Zimmermann C, Isenberg SR. CMAJ. 2024;
Publications
Characteristics of opioid toxicity deaths among adolescents and young adults in Ontario prior to and during the COVID-19 pandemic
Akbar S, Iacono A, Yang J, Antoniou T, Juurlink D, Sheikh H, Kurdyak P, Wu F, Cheng C, Leece P, Kolla G, Emblem J, Shearer D, Gomes T. J Adolesc Health. 2024; Apr 9 [Epub ahead of print].
On-time denosumab dosing recovered rapidly during the COVID-19 pandemic, yet remains suboptimal
Rzepka AM, Cheung AM, Kim S, Gomes T, Cadarette SM. JBMR Plus. 2024; 8(5):ziae027. Epub 2024 April 9, 2024.
Alpha-1 adrenergic antagonists and the risk of hospitalization or death in non-hospitalized patients with COVID-19: a population-based study
Antoniou T, McCormack D, Tadrous M, Gomes T. Fundam Clin Pharmacol. 2024; Apr 4 [Epub ahead of print].
Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: a population-based analysis
Ledlie S, Tadrous M, Bayoumi AM, McCormack D, Cheng C, Besharah J, Munro C, Gomes T. Int J Drug Policy. 2024; Mar 23 [Epub ahead of print].
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada
Greenwald ZR, Werb D, Feld JJ, Austin PC, Fridman D, Bayoumi AM, Gomes T, Kendall CE, Lapointe-Shaw L, Scheim AI, Bartlett SR, Benchimol EI, Bouck Z, Boucher LM, Greenaway C, Janjua NZ, Leece P, Wong WWL, Sander B, Kwong JC. J Clin Epidemiol. 2024; Mar 22 [Epub ahead of print].
A population-based time-series analysis of opioid agonist treatment dispensed during pregnancy
Schmidt RA, Everett K, Perez-Brumer A, Strike C, Rush B, Gomes T. Addiction. 2024; Mar 13 [Epub ahead of print].
Varying circumstances surrounding opioid toxicity deaths across ethnoracial groups in Ontario, Canada: a population-based descriptive crosssectional study
Campbell TJ, Kitchen SA, Tadrous M, Damba C, Johnson CH, Smoke A, Crichlow F, Gomes T. BMJ Public Health. 2024; 2:e000480. Epub 2024 March 13.
Patterns of publicly funded naltrexone use among patients diagnosed with alcohol use disorder in Ontario
Tourchian N, McCormack D, Leece P, Tadrous M, Gomes T. Alcohol Alcohol. 2024; 59(2):agad091. Epub 2024 Jan 31.
Impact of COVID-19 pandemic on prescription stimulant use among children and youth: a population-based study
Antoniou T, Pajer K, Gardner W, Penner M, Lunsky Y, McCormack D, Tadrous M, Mamdani M, Gozdyra P, Juurlink DN, Gomes T. Eur Child Adolesc Psychiatry. 2024; Jan 5 [Epub ahead of print].